Health
Ponatinib identified as a potent inhibitor of SARS-CoV2-induced cytokine storm – News-Medical.Net
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor…
To date, vaccination efforts have commenced stemming the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Alongside vaccine campaigns, scientists race to find effective drugs to combat the infection.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News19 hours agoBrisbane rising on global rankings, but still behind southern capitals